Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05643027

A Novel Intervention for Patients With Cancer

Conditions: Substance Use, Cancer, Psychological

Sex: All
Ages: 18 Years – 99 Years
Phase: NA
Enrollment: 20
Sponsor: Dana-Farber Cancer Institute

Location: United States

Summary

This research study is being done to develop an intervention for psychological symptoms that patients diagnosed with cancer may experience. Psychological symptoms may include thoughts, feelings, emotions, and memoriesThe names of the study intervention and research activities involved in this study are/is:Acceptance & Commitment Therapy (ACT) for Cancer (involving 6 sessions with a licensed clinical psychologist)QuestionnairesPost-study interviewConsistent with the NIH Stage Model for Behavioral Intervention Development, the investigators have adapted an existing, empirically-validated intervention, Acceptance and Commitment Therapy (ACT), to address substance use disorder risk during cancer care. The core components of ACT are particularly well-suited to address the psychological processes underlying opioid misuse in individuals treated for cancer pain. The overarching aim is to assess the feasibility and acceptability of the intervention by conducting a randomized pilot trial of the revised intervention ("ACTION") for cancer patients on opioid therapy, and at risk for SUD.

Eligibility Criteria

Inclusion Criteria:at least 18 years oldhave an estimated survival time of at least 6 months (as estimated by palliative care provider)score at least 4 on the Opioid Risk Tool (ORT)have been diagnosed with any cancer, including hematologic malignanciesperformance status criterion of 0, 1, or 2 [ with 0 indicating that the patient is asymptomatic, 1 that the patient is symptomatic but fully ambulatory, and 2 that the patient is symptomatic and in bed <50% of the day]Exclusion Criteria:Patients with a score at least 3 to ensure that all enrolled patients are able to participate in the intervention, complete assessments, ensure that no patients who are too sick to participate are enrolled; this will enhance the rigor of the study)currently be on opioid therapynot meet criteria for current substance use disorderassessed by the Diagnostic & Statistical Manual of mental disorders; DSM-5 or be receiving substance use disorder treatment; and speak and comprehend English sufficiently to be able to participate in psychotherapy.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05643027). StuddyBuddy aggregates publicly available trial information.